D-二聚体市场快照

Study Period: | 2018 - 2026 |
Base Year: | 2021 |
Fastest Growing Market: | Asia Pacific |
Largest Market: | North America |
CAGR: | >5.6 % |
![]() |
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
预计 D-二聚体市场在预测期内将见证健康的复合年增长率。推动市场增长的主要因素是多种心血管适应症、急性冠状动脉综合征、动脉或静脉血栓栓塞、心房颤动等病理状况的全球流行率和非病理状况(例如老年人口水平的上升)。血浆中的 D-二聚体增加。例如,根据 2018 年发布的《全球健康与健康报告》,美国约有 40% 的成年人被诊断出患有与血液疾病相关的某些或其他心血管疾病,这直接导致对有效治疗和先进凝血检测的需求增加在整个预测期内推动市场增长的技术。
报告范围
D-二聚体是一种纤维蛋白降解产物(FDP),它具有两个交联的纤维蛋白D片段,由称为纤维蛋白溶解的血凝块降解形成。只有当血液凝固系统由于弥散性血管内凝血或血栓形成而被激活并因此激活止血系统时,D-二聚体才会在血浆中形成。由于 D-二聚体测试的成本效益、高精度和缺乏放射干预,推动了全球 D-二聚体市场收入,因此对 D-二聚体测试的需求正在增加。
By Testing Method | |
Point of Care Testing | |
Laboratory Testing |
By Application | |
Deep Vein Thrombosis (DVT) | |
Pulmonary Embolism (PE) | |
Venous Thromboembolism (VTE) | |
Others |
By Distribution Channel | |
Diagnostic Laboratories | |
Hospitals | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
主要市场趋势
肺栓塞部分预计将在预测期内实现强劲增长
- 肺栓塞部分的增长归因于这种疾病的全球流行率不断提高,这是由于女性血浆 d-二聚体水平的上升和老年人口的增加以及相关疾病负担的增加。另一方面,由于全球新病例的增加,深静脉血栓形成 (DVT) 检测也可能在预测期内出现最高增长率。例如,根据英国国民健康服务 (NHS) 情况说明书 (2019),每年,英国每 1,000 人中就有一人受到 DVT 的影响,此外还有肥胖人口和 40 岁以上的人。这一因素正在推动这一细分市场并为全球市场收入的增长做出贡献。
- 根据最终用户,预计医院部门将主导 d-二聚体市场。占主导地位的原因是住院患者人数增加,以便按照医生的规定进行心血管疾病和血液疾病的早期诊断。另一方面,由于发达国家采用先进技术和 Cobas h 232 POC 系统等新系统的可用性,诊断实验室可能见证最高增长,该系统可用于救护车和急诊室驾驶等不同环境预测期内的全球 d-二聚体市场。

To understand key trends, Download Sample Report
北美在市场上占主导地位,预计在预测期内也会如此。
预计北美将在整个预测期内主导整个 D-二聚体市场。主导地位是由于心肺疾病和血液疾病的患病率上升,如静脉血栓栓塞、中风、弥散性血管内凝血在庞大的老年人群中产生了对 D-二聚体测试市场的更高需求。例如,根据美国疾病控制与预防中心 (CDC) 于 2019 年 3 月发布的报告,深静脉血栓形成 (DVT) 的风险随着肥胖和 50 岁以上的增加而增加。据 CDC 估计,大约美国每年可能有 900,000 人受到 DVT 的影响,这直接推动了该地区 D-二聚体检测市场的增长。还,

To understand geography trends, Download Sample Report
竞争格局
D-二聚体市场竞争适度,由几个主要参与者组成。很少有主要参与者建立合作伙伴关系以开发新的方法和测试套件,而其他主要参与者则通过与分销商合作来增加他们的销售人员,以提高他们在全球的市场地位。例如,2017 年 10 月,雅培收购了全球快速即时诊断制造商 Alere Inc,并成为领先的护理检测产品组合之一,在各地区的关键业务领域取得领先地位,预计将推动整个预测期内的全球 D-二聚体市场增长。目前主导市场的一些公司是 F. Hoffmann-La Roche Ltd、Abbott Laboratories、Siemens AG、Bio-Rad Laboratories Inc 和 Thermo Fisher Scientific。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Geriatric Population Along with Rise in Disposable Income
-
4.2.2 Rise in Global Prevalence of Cardiopulmonary Disorders such as Stroke and Pulmonary Embolism
-
-
4.3 Market Restraints
-
4.3.1 Stringent Regulation
-
4.3.2 Limitations Associated with the Tests
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Testing Method
-
5.1.1 Point of Care Testing
-
5.1.2 Laboratory Testing
-
-
5.2 By Application
-
5.2.1 Deep Vein Thrombosis (DVT)
-
5.2.2 Pulmonary Embolism (PE)
-
5.2.3 Venous Thromboembolism (VTE)
-
5.2.4 Others
-
-
5.3 By Distribution Channel
-
5.3.1 Diagnostic Laboratories
-
5.3.2 Hospitals
-
5.3.3 Others
-
-
5.4 Geography
-
5.4.1 North America
-
5.4.1.1 United states
-
5.4.1.2 Canada
-
5.4.1.3 Mexico
-
-
5.4.2 Europe
-
5.4.2.1 Germany
-
5.4.2.2 United Kingdom
-
5.4.2.3 France
-
5.4.2.4 Italy
-
5.4.2.5 Spain
-
5.4.2.6 Rest of Europe
-
-
5.4.3 Asia-Pacific
-
5.4.3.1 China
-
5.4.3.2 Japan
-
5.4.3.3 India
-
5.4.3.4 Australia
-
5.4.3.5 South Korea
-
5.4.3.6 Rest of Asia-Pacific
-
-
5.4.4 Middle-East and Africa
-
5.4.4.1 GCC
-
5.4.4.2 South Africa
-
5.4.4.3 Rest of Middle-East and Africa
-
-
5.4.5 South America
-
5.4.5.1 Brazil
-
5.4.5.2 Argentina
-
5.4.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Abbott Laboratories
-
6.1.2 Bio-Rad Laboratories Inc
-
6.1.3 Danaher Corporation
-
6.1.4 Beckton Dickinson
-
6.1.5 BioMerieux
-
6.1.6 F Hoffmann-La Roche AG
-
6.1.7 Siemens AG
-
6.1.8 Sysmex Corporation
-
6.1.9 Merck KGaA
-
6.1.10 Thermo Fisher Scientific
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The D-Dimer Market market is studied from 2018 - 2026.
What is the growth rate of D-Dimer Market?
The D-Dimer Market is growing at a CAGR of >5.6% over the next 5 years.
Which region has highest growth rate in D-Dimer Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in D-Dimer Market?
North America holds highest share in 2021.
Who are the key players in D-Dimer Market?
F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Thermo Fisher Scientific, Abbott Laboratories, Siemens AG are the major companies operating in D-Dimer Market.